Volume | 3,671 |
|
|||||
News | - | ||||||
Day High | 3.415 | Low High |
|||||
Day Low | 3.11 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
TFF Pharmaceuticals Inc | TFFP | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.12 | 3.11 | 3.415 | 3.11 | 3.135 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
68 | 3,671 | $ 3.24 | $ 11,909 | - | 3.00 - 21.2475 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:44:44 | 4 | $ 3.29 | USD |
TFF Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.36M | 2.37M | - | 734k | -21.24M | -8.98 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
TFF Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFFP Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 4.02 | 4.26 | 3.00 | 3.46 | 29,347 | -0.91 | -22.64% |
1 Month | 7.96 | 8.20 | 3.00 | 5.31 | 44,105 | -4.85 | -60.93% |
3 Months | 5.07 | 11.00 | 3.00 | 6.44 | 31,854 | -1.96 | -38.66% |
6 Months | 8.25 | 11.00 | 3.00 | 7.24 | 102,934 | -5.14 | -62.30% |
1 Year | 15.75 | 21.2475 | 3.00 | 9.57 | 126,291 | -12.64 | -80.25% |
3 Years | 299.50 | 307.00 | 3.00 | 103.07 | 154,268 | -296.39 | -98.96% |
5 Years | 125.75 | 528.50 | 3.00 | 197.26 | 179,429 | -122.64 | -97.53% |
TFF Pharmaceuticals Description
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. |